ANTI-FIBROTIC EFFECTS OF CYCLOPHOSPHAMIDE ON BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA

dc.contributor.authorOzgen, M.
dc.contributor.authorKoca, S.
dc.contributor.authorUstundag, B.
dc.contributor.authorOzercan, I.
dc.contributor.authorDagli, F.
dc.contributor.authorIsik, A.
dc.date.accessioned2026-08-12T17:40:14Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpageS159
dc.identifier.issn0392-856X
dc.identifier.issue2
dc.identifier.startpageS159
dc.identifier.urihttps://hdl.handle.net/11508/59181
dc.identifier.volume28
dc.identifier.wosWOS:000279203200309
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleANTI-FIBROTIC EFFECTS OF CYCLOPHOSPHAMIDE ON BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA
dc.typeConference Object

Dosyalar